Live from the NIH registry
Studies recruiting near Gainesville right now
Top 25 of 157 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Physicians Research Associates, LLC /ID# 255675 — Lawrenceville, Georgia (24.8 mi)
· Sponsor: AbbVie
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 600 participants sought
North Georgia Rheumatology Group PC — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Takeda
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Emory Johns Creek Hospital — Johns Creek, Georgia (27.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Cleaver Medical Group — Cumming, Georgia (18.7 mi)
· Sponsor: Incyte Corporation
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
ProCare Prosthetics x Ottobock.care — Buford, Georgia (15.4 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Georgia Nephrology — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight
Phase 3
Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Gainesville, Georgia (0.6 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 144 participants sought
Cleaver Medical Group Dermatology- Site Number : 8400008 — Cumming, Georgia (18.7 mi)
· Sponsor: Sanofi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Center for Advanced Research & Education — Gainesville, Georgia (0.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Iron Deficiency Anemia
Phase 3
Interventional 75 participants sought
Gwinnett Research Institute — Buford, Georgia (15.4 mi)
· Sponsor: AMAG Pharmaceuticals, Inc.
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Center for Advanced Research & Education — Gainesville, Georgia (0.6 mi)
· Sponsor: Hoffmann-La Roche
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Brain Cancer, Breast Cancer
N/A
Observational 7,000 participants sought
North Georgia Health System — Gainesville, Georgia (0.6 mi)
· Sponsor: Adela, Inc
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Emory Johns Creek Hospital — Johns Creek, Georgia (27.8 mi)
· Sponsor: SWOG Cancer Research Network
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Northeast Georgia Medical Center-Gainesville — Gainesville, Georgia (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
One Health Research Clinic Inc. — Johns Creek, Georgia (27.8 mi)
· Sponsor: pH-D Feminine Health LLC
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
Northeast Georgia Medical Center — Gainesville, Georgia (0.6 mi)
· Sponsor: HistoSonics, Inc.
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Hypertriglyceridemia
Phase 3
Interventional 869 participants sought
Research Site 237 — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Arrowhead Pharmaceuticals
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 2
Interventional 630 participants sought
Research Site — Gainesville, Georgia (0.6 mi)
· Sponsor: AstraZeneca
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Physicians Research Associates LLC — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Zucara Therapeutics Inc.
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Phase 3
Interventional 384 participants sought
Salveo Integrative Health Inc — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 2
Interventional 60 participants sought
Investigator Site # 1 — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Akebia Therapeutics
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Northside Hospital-Forsyth — Cumming, Georgia (18.7 mi)
· Sponsor: NRG Oncology
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Suwanee, Georgia (21.5 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
NSC Research Inc — Johns Creek, Georgia (27.8 mi)
· Sponsor: Boehringer Ingelheim